NF-κB inhibition delays DNA damage-induced senescence and aging in mice.
Jeremy S Tilstra,Andria R Robinson,Jin Wang,Siobhán Q Gregg,Cheryl L Clauson,Daniel P Reay,Luigi A Nasto,Claudette M St Croix,Arvydas Usas,Nam Vo,Johnny Huard,Paula R Clemens,Donna B Stolz,Denis C Guttridge,Simon C Watkins,George A Garinis,Yinsheng Wang,Laura J Niedernhofer,Paul D Robbins
DOI: https://doi.org/10.1172/JCI45785
IF: 19.456
2012-01-01
Journal of Clinical Investigation
Abstract:The accumulation of cellular damage, including DNA damage, is thought to contribute to aging-related degenerative changes, but how damage drives aging is unknown. XFE progeroid syndrome is a disease of accelerated aging caused by a defect in DNA repair. NF-kappa B, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases. To determine whether NF-kappa B drives aging in response to the accumulation of spontaneous, endogenous DNA damage, we measured the activation of NF-kappa B in WT and progeroid model mice. As both WT and progeroid mice aged, NF-kappa B was activated stochastically in a variety of cell types. Genetic depletion of one allele of the p65 subunit of NF-kappa B or treatment with a pharmacological inhibitor of the NF-kappa B-activating kinase, IKK, delayed the age-related symptoms and pathologies of progeroid mice. Additionally, inhibition of NF-kappa B reduced oxidative DNA damage and stress and delayed cellular senescence. These results indicate that the mechanism by which DNA damage drives aging is due in part to NF-kappa B activation. IKK/NF-kappa B inhibitors are sufficient to attenuate this damage and could provide clinical benefit for degenerative changes associated with accelerated aging disorders and normal aging.